Detection of Human Anti-Trypanosoma cruzi Antibody with Recombinant Fragmented Ribosomal P Protein
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Chagas disease is caused by the protozoan parasite Trypanosoma cruzi, and is endemic in many Latin Ameri- can countries. Diagnosis is based on serologic testing and the WHO recommends two or more serological tests for confir- mation. Acidic ribosomal P protein of T. cruzi showed strong reactivity against positive sera of patients, and we cloned the protein after fragmenting it to enhance its antigenicity and solubility. Twelve positive sera of Chagas disease patients were reacted with the fragmented ribosomal P protein using western blot. Detection rate and density for each fragment were determined. Fragments F1R1, F1R2, and F2R1 showed 100% rate of detection, and average density scoring of 2.00, 1.67, and 2.42 from a maximum of 3.0, respectively. Therefore, the F2R1 fragment of the ribosomal P protein of T. cruzi could be a promising antigen to use in the diagnosis of Chagas disease in endemic regions with high specificity and sensitivity.
Abstract
Chagas disease is caused by the protozoan parasite Trypanosoma cruzi, and is endemic in many Latin Ameri- can countries. Diagnosis is based on serologic testing and the WHO recommends two or more serological tests for confir- mation. Acidic ribosomal P protein of T. cruzi showed strong reactivity against positive sera of patients, and we cloned the protein after fragmenting it to enhance its antigenicity and solubility. Twelve positive sera of Chagas disease patients were reacted with the fragmented ribosomal P protein using western blot. Detection rate and density for each fragment were determined. Fragments F1R1, F1R2, and F2R1 showed 100% rate of detection, and average density scoring of 2.00, 1.67, and 2.42 from a maximum of 3.0, respectively. Therefore, the F2R1 fragment of the ribosomal P protein of T. cruzi could be a promising antigen to use in the diagnosis of Chagas disease in endemic regions with high specificity and sensitivity.
참고문헌 (10)
- Rassi A Jr, "Chagas disease", Lancet, 375, pp.1388~1402 (2010)
- Hotez PJ, "The neglected tropical diseases of Latin America and the Caribbean : a review of disease burden and distribution and a roadmap for control and elimination", PLoS Negl Trop Dis, 2, pp.e300~ (2008)
- Mathers CD, "Measuring the burden of neglected tropical diseases : the global burden of disease framework", PLoS Negl Trop Dis, 1, pp.e114~ (2007)
- Prata A, "Clinical and epidemiological aspects of Chagas disease", Lancet Infect Dis, 1, pp.92~100 (2001)
- "Chagas disease (American trypanosomiasis)"[URL]
- "Second WHO consultation on the development of a WHO reference panel for the control of Chagas diagnostic tests"[URL]
- Frasch AC, "Comparison of genes encoding Trypanosoma cruzi antigens", Parasitol Today, 7, pp.148~151 (1991)
- Houghton RL, "A multi-epitope synthetic peptide and recombinant protein for the detection of antibodies to Trypanosoma cruzi in radioimmunoprecipitationconfirmed and consensus-positive sera", J Infect Dis, 179, pp.1226~1234 (1999)
- Gomez Barroso JA, "Chagas disease : a homology model for the three-dimensional structure of the Trypanosoma cruzi ribosomal P0 antigenic protein", Eur Biophys J, 43, pp.361~366 (2014)
- Bocharov EV, "From structure and dynamics of protein L7", L12 to molecular switching in ribosome, 2004, pp.279, 17697~17706